(13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
Modify Date: 2025-10-23 18:49:21
(13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid structure
|
Common Name | (13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid | ||
|---|---|---|---|---|
| CAS Number | 20897-91-0 | Molecular Weight | 354.481 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 529.3±50.0 °C at 760 mmHg | |
| Molecular Formula | C20H34O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 288.0±26.6 °C | |
Use of (13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid15(R)-Prostaglandin E1 (15(R)-PGE1) is the “unnatural” C-15 stereoisomer of PGE1. |
| Name | 15(R)-Prostaglandin E1 |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 529.3±50.0 °C at 760 mmHg |
| Molecular Formula | C20H34O5 |
| Molecular Weight | 354.481 |
| Flash Point | 288.0±26.6 °C |
| Exact Mass | 354.240631 |
| PSA | 94.83000 |
| LogP | 2.24 |
| Vapour Pressure | 0.0±3.2 mmHg at 25°C |
| Index of Refraction | 1.546 |
| Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15R)- |
| Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)- |
| 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid |
| 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid |
| (13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid |
| Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l- |
| Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (13E)- |
| Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo- |
| (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid |
| Cyclopentaneheptanoic acid, 3-hydroxy-2- (3-hydroxy-1-octenyl)-5-oxo-, (+)- |
| (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid |
| 9-oxo-11alpha,15r-dihydroxy-prost-13e-en-1-oic acid |
| 15-epi pge1 |
| (11α,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid |
| l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid |